Skip to main content

Table 2 Prevalence and sites of 234 locoregional recurrence in 186 patients

From: Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy

Sites of recurrence

Number

%*

Isolated chest wall

82

35.0

Chest wall + Regional LN

23

9.8

  Chest wall + axillary LN + SC LN

3

1.3

  Chest wall + SC LN + IMN

5

2.1

  Chest wall + axillary LN

1

0.4

  Chest wall + SC LN

6

2.6

  Chest wall + IMN

8

3.4

Regional LN

81

34.6

  Axillary LN + SC LN + IMN

2

0.9

  Axillary LN + SC LN

6

2.6

  SC LN + IMN

7

3.0

  Axillary LN

16

6.8

  SC LN

42

17.9

  Internal mammary nodes

8

3.4

  1. IMN Internal mammary nodes, LN Lymph nodes, SCA Supraclavicular;
  2. *, percentage of total 234 locoregional recurrence
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us